Literature DB >> 23557670

Development and application of a universal Taqman real-time PCR for quantitation of duck hepatitis B virus DNA.

Yawen Wang1, Yiping Li, Cuiling Yang, Lingyun Hui, Qunying Han, Lieting Ma, Quanying Wang, Guangxiao Yang, Zhengwen Liu.   

Abstract

To develop a quantitative assay for universal detection of duck hepatitis B virus (DHBV) DNA, a Taqman real-time fluorescent quantitative polymerase chain reaction (FQ-PCR) assay was developed using primers and probes based on genomic sequences located at nucleotide 241-414 of the DHBV Core region which possesses the highest homology among the 44 DHBV genomes available in Genbank. The DHBV Core gene cloned in pGEM-T was used to generate DHBV DNA standard. The assay had a lowest detection limit of 10(3) copies/ml and a good linear standard curve (Y=-3.989X+49.086, r(2)=0.9993) over a wide range of input DHBV DNA (10(3) to 10(10) copies/ml). The standard deviation of intra- and inter-assay was 0.01-0.06 and 0.05-0.16, respectively, and the coefficient of variation was 1.3-1.8%. The specificity of the assay was validated using duck hepatitis virus type 1, hepatitis B virus, and E. coli DNA. Comparison of ABI 7300 and Bio-Rad iQ5 PCR instruments yielded highly consistent results. The assay showed a positive rate of 63.8% (51/80) DHBV DNA in peripheral blood and liver tissue from ducks from Xi'an, China. The FQ-PCR developed is highly sensitive, specific, reproducible and versatile, and may be used to universally detect DHBV DNA of different DHBV strains.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557670     DOI: 10.1016/j.jviromet.2013.03.025

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

1.  Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.

Authors:  Yiping Li; Zhengwen Liu; Lingyun Hui; Xi Liu; Ai Feng; Wei Wang; Lin Zhang; Na Li; Guoqing Zhou; Quanli Wang; Qunying Han; Yi Lv; Quanying Wang; Guangxiao Yang; Yawen Wang
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

2.  Quality Control of Widely Used Therapeutic Recombinant Proteins by a Novel Real-Time PCR Approach.

Authors:  Babak Mamnoon; Taghi Naserpour Farivar; Ahmad Reza Kamyab; Dariush Ilghari; Ali Khamesipour; Mohsen Karimi Arzenani
Journal:  Iran Biomed J       Date:  2015-06-06

3.  Simple and visible detection of duck hepatitis B virus in ducks and geese using loop-mediated isothermal amplification.

Authors:  Jun Ji; Xin Xu; Qianqian Wu; Xueyu Wang; Wanyu Li; Lunguang Yao; Yunchao Kan; Lu Yuan; Yingzuo Bi; Qingmei Xie
Journal:  Poult Sci       Date:  2020-01-24       Impact factor: 3.352

4.  Inhibition of duck hepatitis B virus replication by mimic peptides in vitro.

Authors:  Hongyu Jia; Changhong Liu; Ying Yang; Haihong Zhu; Feng Chen; Jihong Liu; Linfu Zhou
Journal:  Exp Ther Med       Date:  2015-09-21       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.